newsalert.com
Albert Erani Named to Organogenesis Board of Directors
Business Wire - November 13, 1998 15:57
CANTON, Mass.--(BW Healthwire)--Nov. 13, 1998--Organogenesis Inc. (AMEX:ORG) today announced the election of Albert
Erani to its Board of Directors, effective November 10, 1998. Mr. Erani is a significant shareholder in Organogenesis.
Mr. Erani is a co-founder of A&E Stores, Inc., which operates approximately 80 stores. He is a substantial shareholder in Vanlex
Stores, Inc. and also holds a major share in three international wholesale apparel companies.
"We are pleased to have Albert join the Board of Directors," said Herbert M. Stein, Chairman and Chief Executive Officer of
Organogenesis. "As a successful entrepreneur, Albert brings to the Board proven business acumen, while also providing further
representation of the interests of shareholders.
Organogenesis Inc. designs, develops and manufactures medical products containing living cells and/or natural connective tissue.
The Company's product development focus includes living tissue replacements, cell-based organ assist devices and other
tissue-engineered products. Lead product Apligraf(R) has been approved for the treatment of venous leg ulcers in the US and
Canada; Novartis Pharma AG has global Apligraf marketing rights. Organogenesis' portfolio also includes the
GRAFTPATCH(TM) surgical product (also FDA-cleared for marketing), Vitrix(TM) connective tissue replacement product, a
bioartificial liver, a vascular graft and injectable engineered collagen.
CONTACT: Organogenesis
Carol Hausner, 781/575-0775
Director, Investor and Public Relations
|
